Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial-Reference-Cited by-同舟云学术

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

Published:2011-10-05 Issue:10 Volume:30 Page:682-689
ISSN:1000-467X
Container-title:Chinese Journal of Cancer
language:
Short-container-title:Chin J Cancer

Author:

Guan Zhong-Zhen,Xu Jian-Ming,Luo Rong-Cheng,Feng Feng-Yi,Wang Li-Wei,Shen Lin,Yu Shi-Ying,Ba Yi,Liang Jun,Wang Dong,Qin Shu-Kui,Wang Jie-Jun,He Jing,Qi Chuan,Xu Rui-Hua

Publisher

Editorial Office of Chinese Journal of Cancer

Subject

Oncology

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overall survival with non-proportional hazards in first-line treatment for patients with metastatic colorectal cancer: Systematic review and network meta-analysis;Heliyon;2024-08

2. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials;BMC Cancer;2024-07-24

3. Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta‐analysis;Cancer Medicine;2023-12

4. Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study;South Asian Journal of Cancer;2023-10-13

5. Different doses of bevacizumab in combination with chemotherapy for advanced colorectal cancer: a meta-analysis and Bayesian analysis;International Journal of Colorectal Disease;2023-06-08